Indeed, most studies on the HGF/MET-mediated phosphorylation of STMN1 have not used prostate cancer cell lines, nor have they investigated in detail the regulation of both tSTMN1 and STMN1 phosphorylation during cell cycle progression. The gene discussed is MET; the disease is prostate cancer.